KLSE (MYR): AWANTEC (5204)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.36
Today's Change
0.00 (0.00%)
Day's Change
0.35 - 0.36
Trading Volume
340,500
2024-10-09
2024-10-09
2024-10-07
2024-10-07
2024-10-03
2024-10-02
2024-10-02
2024-09-30
hng33
20,382 posts
Posted by hng33 > 2017-07-25 09:19 | Report Abuse
SKIN will be a build, operate, maintain and transfer model and fund raising is through bond issuance with gov concession payout as backup. Therefore, investor need to understand on accounting IFRIC 12: Service Concession Arrangements which explains accounting treatment for concession biz.
Accounting 101: accruals concept means that revenue and costs are recognised as and when they are incurred, not when cash payment is received or paid. So my interpretation is revenue and costs should be recognised in the first 3 years when work is done, not when payment is received in the next 12 years while maintenance revenue will be recognised in the 12 years maintenance period. In other words, my take is that the development revenue for the build and deployment phase should be recognised by progress for the first 3 years while maintenance revenue will be recognised when maintenance works are carried out.
http://klse.i3investor.com/blogs/purelysharing/109447.jsp
Based on above calculation, There will some medication to take into account effective stake 70% and MSC status on tax exemption. Prestaring net profit on Skin
Development stage: Year 1
Profit before tax: RM 67.5m
Profit after tax (MSC status): RM 35.91 + 20.25m (tax exempt)= RM 56.2m
EPS: 11.6sen
EPS (70% stake): 8.15sen
Development stage: Year 2
Profit before tax: RM 113.4m
Profit after tax (MSC status): RM 60.3 + 34.02m (tax exempt)= RM 94.32m.2m
EPS: 19.5sen
EPS (70% stake): 13.68sen
Development stage: Year 3
Profit before tax: RM 159.3m
Profit after tax (MSC status): RM 84.75 + 47.79m (tax exempt)= RM 135.54m.2m
EPS: 27.45sen
EPS (70% stake): 19.21sen